 SAN CARLOS, Calif., Dec. 14, 2020 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDABioCardia or the Company today announced it has entered into definitive agreements with investors for the purchase and sale of 1,888,889 shares of its common stock at a purchase price of 4.75 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about December 16, 2020, subject to the satisfaction of customary closing conditions. 